It comprises two enzymes , glyoxalase I and glyoxalase 11, and a c a t a l y t i c amount o f reduced glutathione.
Glyoxalase I catalyses t h e formation o f S-D-lactoylglutathione from methylglyoxal and reduced glutathione.
Glyoxalase I 1 catalyses t h e hydrolysis o f S-D-1 actoyl g l utathione t o D-1 actate and reduced glutathione. The glyoxalase system i s present i n the cytosol o f a l l c e l l s [l] .
Recent research has shown t h a t the glyoxalase system i s modified during hyperglycaemia i n human red blood c e l l s i n v i t r o [2] , and i n red blood c e l l s from (ob/ob) obese mice and streptozotocin-induced d i a b e t i c mice i n vivo [3] .
The modification o f the glyoxalase system has been l i n k e d t o t h e development o f c l i n i c a l d i a b e t i c complications [l] . We describe here c h a r a c t e r i s t i c s o f t h e red blood c e l l glyoxalase system i n c l i n i c a l diabetes m e l l i t u s .
Blood samples were taken from 43 insulin-dependent t h e concentration o f GSH) f o r upto 6 weeks and showed no s i g n i f i c a n t change i n glyoxalase a c t i v i t i e s and metabolite concentrations during t h i s period.
The concentration o f methylglyoxal i n blood samples was determined by d e r i v a t i s a t i o n w i t h 1,2-diamino-4,5-dimethoxy-benzene and a n a l y t i c a l reverse hase high performance 1 i q u i d chromatography (HPLCf o f t h e uinoxaline adduct w i t h spectrophotometric detection 1141 . The concentration o f S-o-lactoylglutathione i n blood samples was determined, a f t e r strong anion exchange sol i d phase extraction, by reverse phase HPLC w i t h spectrophotometric detection a t 233 nm [5] .
The concentration o f o-lactate i n blood samples was determined by endpoint enzymatic assay w i t h o -l a c t i c dehydrogenase and fluorometric detection [6] . The concentration o f reduced glutathione (GSH) i n blood samples was determined as non-protein sulphydryl by reaction w i t h Ellman's reagent [7] .
The a c t i v i t i e s o f glyoxalase I and glyoxalase I 1 i n red blood c e l l s were determined by the spectrophotometric methods described The a c t i v i t y o f glyoxalase I was s i g n i f i c a n t l y increased i n IDDM and NIDDM, r e l a t i v e t o normal controls.
The a c t i v i t y o f glyoxalase 11 was s i g n i f i c a n t l y increased i n NIDDM r e l a t i v e t o normal controls. ------- ----- The concentration o f GSH was n o t s i g n i f i c a n t l y changed i n IDDM and NIDDM patients, r e l a t i v e t o normal c o n t r o l s ( M . 0 5 ) .
There were s i g n i f i c a n t increases i n t h e concentrations of methylglyoxal and o-lactate i n blood samples from IDDM and NIDDM, r e l a t i v e t o normal controls. The concentration o f S-o-lactoylglutathione i n blood samples from d i a b e t i c p a t i e n t s (IDDM and NIDDM) was s i g n i f i c a n t l y increased r e l a t i v e t o controls: (mean
There was an increase i n a l l glyoxalase metabolites i n IDDM and NIDDM and an up-regulation o f glyoxalase a c t i v i t i e s , consistent w i t h increased f l u x through t h e glyoxalase pathway i n diabetes m e l l i t u s .
The changes i n glyoxalase a c t i v i t i e s may p a r t l y be due t o decreased red blood c e l l l i f e s p a n [9] b u t o t h e r regulatory f a c t o r s may be involved.
The increase i n t h e concentrations o f methylglyoxal and S-o-lactoylglutathione may promote sequelae associated w i t h t h e development o f d i a b e t i c complications.
Methylglyoxal binds t o proteins t o produce fluorescent pigments and cross-links [10, 11] .
S-o-Lactoylglutathione induces growth a r r e s t and t o x i c i t y i n p r o l i f e r a t i n g c e l l s [12] which c o n t r i b u t e t o t h e dysfunction o f endothelial c e l l s i n diabetes m e l l i t u s .
The modification o f t h e glyoxalase system i n diabetes m e l l i t u s may be l i n k e d t o t h e development o f d i a b e t i c compl i c a t i ons .
